Detalhe da pesquisa
1.
Systematic analysis of F-box proteins reveals a new branch of the yeast mating pathway.
J Biol Chem
; 294(40): 14717-14731, 2019 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399514
2.
Chromatin complex dependencies reveal targeting opportunities in leukemia.
Nat Commun
; 14(1): 448, 2023 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707513
3.
Impact of supraphysiologic MDM2 expression on chromatin networks and therapeutic responses in sarcoma.
Cell Genom
; 3(7): 100321, 2023 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37492096
4.
Extended-representation bisulfite sequencing of gene regulatory elements in multiplexed samples and single cells.
Nat Biotechnol
; 39(9): 1086-1094, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958785
5.
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036.
NPJ Breast Cancer
; 7(1): 51, 2021 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980863
6.
Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer.
Mol Cancer Res
; 18(11): 1685-1698, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32753473
7.
GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer.
Mol Cancer Res
; 17(7): 1503-1518, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31000582
8.
Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer.
Oncotarget
; 9(21): 15480-15497, 2018 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29643987
9.
Enhancer remodeling regulates epigenetic adaptation and resistance to MEK1/2 inhibition in triple-negative breast cancer.
Mol Cell Oncol
; 4(6): e1300622, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29209639
10.
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
Neuro Oncol
; 19(11): 1481-1493, 2017 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28486691
11.
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex.
Cancer Discov
; 7(3): 302-321, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28108460
12.
Pharmacologic targeting of drug-induced enhancers.
Oncoscience
; 4(5-6): 43-44, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28781985